14-day Premium Trial Subscription Try For FreeTry Free
RSI low/high Values: [ 25 - 75 ]
* StockInvest.us uses dynamically calculated RSI max/min levels to determine when stock is oversold or overbought based on historical behavior.
AI Analysis of NRSN
Powered by GPT-4
Upgraded!
Stock Analysis
Risk Assessment
Trading Strategy

Volatile ride for NeuroSense Therapeutics Ltd. stock price on Friday moving between $1.16 and $1.29
(Updated on May 17, 2024)

Sell candidate since May 09, 2024 Gain 3.08% PDF

The NeuroSense Therapeutics Ltd. stock price fell by -0.82% on the last day (Friday, 17th May 2024) from $1.22 to $1.21. During the last trading day the stock fluctuated 10.78% from a day low at $1.16 to a day high of $1.29. The price has fallen in 6 of the last 10 days and is down by -9.02% for this period. Volume has increased on the last day by 50 thousand shares but on falling prices. This may be an early warning and the risk will be increased slightly over the next couple of days. In total, 80 thousand shares were bought and sold for approximately $96.76 thousand.

The stock lies in the middle of a very wide and falling trend in the short term and further fall within the trend is signaled. Given the current short-term trend, the stock is expected to fall -24.57% during the next 3 months and, with a 90% probability hold a price between $0.83 and $1.24 at the end of this 3-month period.

Ready to grow your portfolio? Here's your beginner's guide to opening a free brokerage account.

NRSN Signals & Forecast

A buy signal was issued from a pivot bottom point on Tuesday, May 14, 2024, and so far it has risen 8.04%. Further rise is indicated until a new top pivot has been found. Furthermore, there is a buy signal from the 3 month Moving Average Convergence Divergence (MACD). Some negative signals were issued as well, and these may have some influence on the near short-term development. The NeuroSense Therapeutics Ltd. stock holds a buy signal from the short-term Moving Average; at the same time, however, the long-term average holds a general sell signal. Since the longterm average is above the short-term average there is a general sell signal in the stock giving a more negative forecast for the stock. On further gains, the stock will meet resistance from the long-term Moving Average at $1.45. On a fall, the stock will find some support from the short-term average at $1.18. A break-up through the long-term average will give another buy signal, while a fall below the short-term average will add another sell signal and strengthen the general signal. NeuroSense Therapeutics Ltd. gained volume on the last day, but on falling prices. In technical terms, this is called divergence and may be an early warning. In some cases, increasing volume on falling prices may be considered positive, but that is mainly in typical "sell-offs". The very low volume increases the risk and reduces the other technical signals issued.

Support, Risk & Stop-loss for NeuroSense Therapeutics Ltd. stock

NeuroSense Therapeutics Ltd. finds support from accumulated volume at $1.18 and this level may hold a buying opportunity as an upwards reaction can be expected when the support is being tested.

This stock has average movements during the day and with good trading volume, the risk is considered to be medium. During the last day, the stock moved $0.125 between high and low, or 10.78%. For the last week, the stock has had daily average volatility of 9.07%.

Our recommended stop-loss: We hold a negative evaluation for this stock. No stop-loss is set.

Trading Expectations (NRSN) For The Upcoming Trading Day Of Monday 20th

For the upcoming trading day on Monday, 20th we expect NeuroSense Therapeutics Ltd. to open at $1.22, and during the day (based on 14 day Average True Range), to move between $1.06 and $1.36, which gives a possible trading interval of +/-$0.155 (+/-12.79%) up or down from last closing price. If NeuroSense Therapeutics Ltd. takes out the full calculated possible swing range there will be an estimated 25.57% move between the lowest and the highest trading price during the day.

Since the stock is closer to the support from accumulated volume at $1.18 (2.48%) than the resistance at $1.25 (3.31%), our systems sees the trading risk/reward intra-day as attractive and believe profit can be made before the stock reaches first resistance..

Is NeuroSense Therapeutics Ltd. stock A Buy?

NeuroSense Therapeutics Ltd. holds several negative signals and we believe that it will still perform weakly in the next couple of days or weeks. We, therefore, hold a negative evaluation of this stock.

Current score: -3.935 Sell Candidate Unchanged

Predicted Opening Price for NeuroSense Therapeutics Ltd. of Monday, May 20, 2024

Fair opening price May 20, 2024 Current price
$1.22 ( 0.689%) $1.21

The predicted opening price is based on yesterday's movements between high, low, and closing price.

Trading levels for NRSN

Fibonacci Support & Resistance Levels

Level Price
Resistance R3 1.34 11.02 %
R2 1.30 7.07 %
R1 1.27 4.63 %
Current price: 1.21
Support S1 1.17 -3.26 %
S2 1.14 -5.70 %
S3 1.09 -9.64 %

Accumulated Volume Support & Resistance Levels

Level Price
Resistance R3 1.39 14.88 %
R2 1.29 6.61 %
R1 1.25 3.31 %
Current price 1.21
Support S1 1.18 -2.48%
S2 1.17 -2.99%
S3 1.15 -4.96%

FAQ

What is the symbol for NeuroSense Therapeutics Ltd. Stock and on which exchange is it traded?
The symbol for NeuroSense Therapeutics Ltd. is NRSN and it is traded on the NASDAQ (NASDAQ Stock Exchange).

Should I buy or sell NeuroSense Therapeutics Ltd. Stock?
NeuroSense Therapeutics Ltd. holds several negative signals and we believe that it will still perform weakly in the next couple of days or weeks. We, therefore, hold a negative evaluation of this stock.

How to buy NeuroSense Therapeutics Ltd. Stock?
NeuroSense Therapeutics Ltd. Stock can be purchased through just about any brokerage firm, including online brokerage services.
Click here for our free guide on how to buy NeuroSense Therapeutics Ltd. Stock.

What's the current price of NeuroSense Therapeutics Ltd. Stock?
As of the end of day on the May 17, 2024, the price of an NeuroSense Therapeutics Ltd. (NRSN) share was $1.21.

What is the 52-week high and low for NeuroSense Therapeutics Ltd. Stock?
The 52-week high for NeuroSense Therapeutics Ltd. Stock is $2.33 and the 52-week low is $0.400.

What is the market capitalization of NeuroSense Therapeutics Ltd. Stock?
As of the May 17, 2024, the market capitalization of NeuroSense Therapeutics Ltd. is 21.148M.

When is the next earnings date for NeuroSense Therapeutics Ltd.?
The upcoming earnings date for NeuroSense Therapeutics Ltd. is Aug 14, 2024.
Click to get the best stock tips daily for free!

About NeuroSense Therapeutics Ltd.

NeuroSense Therapeutics Ltd. NeuroSense Therapeutics Ltd., a clinical-stage biotechnology company, focuses on the discovery and development of treatment for patients suffering from debilitating neurodegenerative diseases. Its lead product, PrimeC, is a novel oral formulation that has completed Phase IIa clinical trials for the treatment of amyotrophic lateral sclerosis. The company's preclinical pipeline includes StabiliC for the treatment of Parkinson's disease; and CogniC ... NRSN Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT